Brief: AFT Pharmaceuticals Notes U.S. FDA Approval For Pascomer Alternative By Japan's Nobelpharma
05/04/2022 02:34
April 5 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* NOTES U.S. FDA APPROVAL FOR PASCOMER ALTERNATIVE BY
JAPAN'S
NOBELPHARMA
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV